Literature DB >> 10644614

Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function.

R M Fryer1, J T Eells, A K Hsu, M M Henry, G J Gross.   

Abstract

We examined the role of the sarcolemmal and mitochondrial K(ATP) channels in a rat model of ischemic preconditioning (IPC). Infarct size was expressed as a percentage of the area at risk (IS/AAR). IPC significantly reduced infarct size (7 +/- 1%) versus control (56 +/- 1%). The sarcolemmal K(ATP) channel-selective antagonist HMR-1098 administered before IPC did not significantly attenuate cardioprotection. However, pretreatment with the mitochondrial K(ATP) channel-selective antagonist 5-hydroxydecanoic acid (5-HD) 5 min before IPC partially abolished cardioprotection (40 +/- 1%). Diazoxide (10 mg/kg iv) also reduced IS/AAR (36.2 +/- 4.8%), but this effect was abolished by 5-HD. As an index of mitochondrial bioenergetic function, the rate of ATP synthesis in the AAR was examined. Untreated animals synthesized ATP at 2.12 +/- 0.30 micromol x min(-1) x mg mitochondrial protein(-1). Rats subjected to ischemia-reperfusion synthesized ATP at 0.67 +/- 0.06 micromol x min(-1) x mg mitochondrial protein(-1). IPC significantly increased ATP synthesis to 1.86 +/- 0.23 micromol x min(-1) x mg mitochondrial protein(-1). However, when 5-HD was administered before IPC, the preservation of ATP synthesis was attenuated (1.18 +/- 0.15 micromol x min(-1) x mg mitochondrial protein(-1)). These data are consistent with the notion that inhibition of mitochondrial K(ATP) channels attenuates IPC by reducing IPC-induced protection of mitochondrial function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644614     DOI: 10.1152/ajpheart.2000.278.1.H305

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  51 in total

Review 1.  Pathophysiological and protective roles of mitochondrial ion channels.

Authors:  B O'Rourke
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

Review 2.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

Review 3.  Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia.

Authors:  Miguel A Pérez-Pinzón
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

4.  The intracellular localization and function of the ATP-sensitive K+ channel subunit Kir6.1.

Authors:  Keat-Eng Ng; Sarah Schwarzer; Michael R Duchen; Andrew Tinker
Journal:  J Membr Biol       Date:  2010-03-20       Impact factor: 1.843

Review 5.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

6.  HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.

Authors:  Hai Xia Zhang; Alejandro Akrouh; Harley T Kurata; Maria Sara Remedi; Jennifer S Lawton; Colin G Nichols
Journal:  J Mol Cell Cardiol       Date:  2010-12-23       Impact factor: 5.000

Review 7.  Cytoprotective channels in mitochondria.

Authors:  Hossein Ardehali
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

Review 8.  Mitochondrial K(ATP) channels in cell survival and death.

Authors:  Hossein Ardehali; Brian O'Rourke
Journal:  J Mol Cell Cardiol       Date:  2005-02-19       Impact factor: 5.000

9.  Ischemic preconditioning enhances fatty acid-dependent mitochondrial uncoupling.

Authors:  Raquel S Carreira; Sayuri Miyamoto; Paolo Di Mascio; Lino M Gonçalves; Pedro Monteiro; Luís A Providência; Alicia J Kowaltowski
Journal:  J Bioenerg Biomembr       Date:  2007-10-05       Impact factor: 2.945

10.  The antiarrhythmic effect of centrally administered rilmenidine involves muscarinic receptors, protein kinase C and mitochondrial signalling pathways.

Authors:  M Iwasaki; Y Hayashi; T Kamibayashi; A Yamatodani; T Mashimo
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.